These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 23647548

  • 1. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
    Wang D, Liu D, Gao J, Liu M, Liu S, Jiang M, Liu Y, Zheng D.
    FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype.
    Gao J, Wang D, Liu D, Liu M, Ge Y, Jiang M, Liu Y, Zheng D.
    Mol Biol Cell; 2015 Sep 15; 26(18):3178-89. PubMed ID: 26224317
    [Abstract] [Full Text] [Related]

  • 3. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
    Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC.
    Cancer Res; 2005 Jun 01; 65(11):4799-808. PubMed ID: 15930300
    [Abstract] [Full Text] [Related]

  • 4. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 5. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR, Shankar S, Chen X, Asim M, Srivastava RK.
    Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373
    [Abstract] [Full Text] [Related]

  • 6. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.
    Mol Cancer Res; 2009 Nov 01; 7(11):1835-44. PubMed ID: 19843632
    [Abstract] [Full Text] [Related]

  • 7. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 8. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.
    Du J, Wang Y, Chen D, Ji G, Ma Q, Liao S, Zheng Y, Zhang J, Hou Y.
    Cancer Lett; 2016 Dec 28; 383(2):145-153. PubMed ID: 27721019
    [Abstract] [Full Text] [Related]

  • 9. RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-κB.
    Guo SY, Liu SG, Liu L, Zhou XJ, Gu Y.
    Oncol Rep; 2012 Feb 28; 27(2):441-6. PubMed ID: 22020406
    [Abstract] [Full Text] [Related]

  • 10. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M, Shinohara H, Taniguchi K, Ueda H, Nishi M, Ryo A, Akao Y.
    Oncotarget; 2015 Sep 22; 6(28):25828-42. PubMed ID: 26304927
    [Abstract] [Full Text] [Related]

  • 11. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
    Kurbanov BM, Fecker LF, Geilen CC, Sterry W, Eberle J.
    Oncogene; 2007 May 17; 26(23):3364-77. PubMed ID: 17160022
    [Abstract] [Full Text] [Related]

  • 12. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL, Qian HL, Zhang TT, Zhou N, Wang HJ, Men XT, Qi W, Zhang PP, Fu M, Liang X, Lin C, Liu YJ.
    Drug Des Devel Ther; 2015 May 17; 9():5671-86. PubMed ID: 26527862
    [Abstract] [Full Text] [Related]

  • 13. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells.
    Tao SF, He HF, Chen Q.
    Mol Cell Biochem; 2015 Apr 17; 402(1-2):93-100. PubMed ID: 25596948
    [Abstract] [Full Text] [Related]

  • 14. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J, Hwangbo C, Lee JJ, Seo J, Lee JH.
    Oncol Rep; 2010 Jan 17; 23(1):229-37. PubMed ID: 19956887
    [Abstract] [Full Text] [Related]

  • 15. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A, Kawakubo T, Nakamura S, Yamamoto K.
    Biol Chem; 2010 Aug 17; 391(8):947-58. PubMed ID: 20482316
    [Abstract] [Full Text] [Related]

  • 16. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
    Thai le M, Labrinidis A, Hay S, Liapis V, Bouralexis S, Welldon K, Coventry BJ, Findlay DM, Evdokiou A.
    Cancer Res; 2006 May 15; 66(10):5363-70. PubMed ID: 16707463
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S, Qu X, Xu C, Zhu Z, Zhang L, Xu L, Song N, Teng Y, Liu Y.
    J Cancer Res Clin Oncol; 2012 Aug 15; 138(8):1279-89. PubMed ID: 22447040
    [Abstract] [Full Text] [Related]

  • 18. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM, Oh JH, Park SA, Ryu CH, Lim JY, Kim DS, Chang JW, Oh W, Jeun SS.
    Stem Cells; 2010 Dec 15; 28(12):2217-28. PubMed ID: 20945331
    [Abstract] [Full Text] [Related]

  • 19. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
    Portanova P, Notaro A, Pellerito O, Sabella S, Giuliano M, Calvaruso G.
    Int J Oncol; 2013 Jul 15; 43(1):121-30. PubMed ID: 23686163
    [Abstract] [Full Text] [Related]

  • 20. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW, Chen MW, Chiu CF, Hong CC, Cheng CC, Hsiao M, Chen CA, Wei LH, Su JL.
    Ann Surg Oncol; 2014 Dec 15; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.